Characterization of interferon-alpha binding sites on human cell lines

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Human interferon-alpha (IFN-alpha) plays a crucial role in antiviral and antitumor responses.
• Understanding the IFN-alpha receptor is key to elucidating its cellular signaling pathways.

Purpose of the Study:

• To characterize the binding sites and molecular complexes formed between human IFN-alpha and its receptor on various human cell lines.
• To investigate the nature of the IFN-alpha receptor and its interaction with IFN-alpha.

Main Methods:

• Crosslinking of iodinated recombinant IFN-alpha-Con1 to cell surface receptors using disuccinimidyl suberate.
• Analysis of IFN-alpha-receptor complexes by molecular weight.
• Treatment of cells with proteases (trypsin) and glycosidases (neuraminidase, mannosidase, beta-galactosidase, endoglycosidase F) to assess receptor properties.

Main Results:

• Four specific IFN-alpha-receptor complexes (118, 138, 159, and 260 kD) were identified on lymphoblastoid, melanoma, and cervical carcinoma cells.
• The 100 kD IFN-alpha receptor appears to bind multiple IFN-alpha molecules, forming the lower molecular weight complexes.
• A 260 kD complex, potentially from receptor dimerization, was observed.
• Trypsin treatment abolished complex formation, while glycosidases did not affect IFN-alpha binding, indicating the glycosylated portion is not the binding domain.

Conclusions:

• The human IFN-alpha receptor is a glycoprotein, but its glycosylation is not essential for IFN-alpha binding.
• The receptor's ability to bind multiple IFN-alpha molecules and potential dimerization contribute to complex formation.
• These findings provide insights into the molecular mechanisms of IFN-alpha cell surface interactions.